Comparison of ATP production in whole blood and lymphocyte proliferation in response to phytohemagglutinin

被引:11
作者
Augustine, Nancy H.
Pasi, Brian M.
Hill, Harry R.
机构
[1] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA
[2] ARUP, Inst Clin & Expt Pathol, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA
关键词
lymphocyte proliferation; cell-mediated immunity; immunodeficiency; severe combined immunodeficiency disease (SCID); CD4; cells; adenosine triphosphate (ATP); luminescence;
D O I
10.1002/jcla.20182
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Lymphocyte proliferation in response to mitogens, phytohemagglutinin (PHA), concanavalin A, pokeweed, and/or specific antigens has been the method of choice for in vitro diagnosis of cell-mediated immune dysfunction. Recently, an assay to measure intracellular adenosine triphosphate (ATP) production in response to PHA has been developed that requires a shorter, overnight incubation. We compared a standard 5- to 7-day lymphocyte mitogen stimulation assay utilizing tritiated thymidine (H-3-thy) incorporation to one in which ATP production in response to PHA by CD4-positive cells is measured in a luminometer that requires only 18-24 hr. A total of 20 patient samples suspected of having decreased cell-mediated immunity submitted for mitogen induced lymphocyte proliferation and 21 normal controls were tested in both assays. A comparison of these two methods has demonstrated that the screening ATP assay has a sensitivity at 24hr of 100% in detecting decreased PHA induced lymphocyte proliferation at 5 days and a specificity of 85% in the samples obtained from normal controls. The data indicate that the ATP assay may be a useful screening tool for more rapid detection of blood samples with decreased cell-mediated immune responses. However, a positive screen should always be confirmed by 3H-thy uptake using mitogens and recall antigens like candida and tetanus.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 17 条
[1]  
*CYL INC, 2005, IMMUKNOW PACK INS
[2]   Introduction to diagnostic laboratory immunology [J].
Fleisher, TA ;
Tomar, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (22) :1823-1834
[3]  
FLETCHER MA, 1994, MANUAL CLIN LAB IMMU, P213
[4]  
HICKLING JK, 1998, EXPERT REV MOL MED, P1, DOI DOI 10.1017/S1462399498000313
[5]  
HILL HR, 1980, PEDIATR CLIN N AM, V27, P805
[6]   Establishing pediatric immune response zones using the Cylex® ImmuKnow™ assay [J].
Hooper, E ;
Hawkins, DM ;
Kowalski, RJ ;
Post, DR ;
Britz, JA ;
Brooks, KC ;
Turman, MA .
CLINICAL TRANSPLANTATION, 2005, 19 (06) :834-839
[7]   Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management [J].
Kowalski, R ;
Post, D ;
Schneider, MC ;
Britz, J ;
Thomas, J ;
Deierhoi, M ;
Lobashevsky, A ;
Redfield, R ;
Schweitzer, E ;
Heredia, A ;
Reardon, E ;
Davis, C ;
Bentlejewski, C ;
Fung, J ;
Shapiro, R ;
Zeevi, A .
CLINICAL TRANSPLANTATION, 2003, 17 (02) :77-88
[8]  
Ling NR, 1975, LYMPHOCYTE STIMULATI
[9]  
MOLLER G, 1972, TRANSPLANT REV, V11, P1
[10]   Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival [J].
Myers, LA ;
Patel, DD ;
Puck, JM ;
Buckley, RH .
BLOOD, 2002, 99 (03) :872-878